CDK9 is dispensable for YAP-driven hepatoblastoma development.
Xinyan ChenAndras KissZsuzsa SchaffKatja EvertYi ZhangSheng ZhongJingxiao WangMatthias EvertDiego F CalvisiXin ChenPublished in: Pediatric blood & cancer (2020)
CDK9 is not a major downstream mediator of YAP oncogenic function in HB development and progression.
Keyphrases